Cyclin E is a more powerful predictor of breast cancer outcome than proliferation

被引：28

作者：

Keyomarsi, K

Tucker, SL

Bedrosian, I

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA

[2] Univ Texas, MD Anderson Canc Ctr, Dept Biomath, Houston, TX 77030 USA

[3] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA

来源：

NATURE MEDICINE | 2003年 / 9卷 / 02期

关键词：

D O I：

10.1038/nm0203-152

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：152 / 152

页数：1

共 8 条

[1] Predicting the future of breast cancer [J].

Borg, Å ;

Fernö, M ;

Peterson, C .

NATURE MEDICINE, 2003, 9 (01) :16-18

[2] Cyclin E and survival in patients with breast cancer. [J].

Keyomarsi, K ;

Tucker, SL ;

Buchholz, TA ;

Callister, M ;

Ding, Y ;

Hortobagyi, GN ;

Bedrosian, I ;

Knickerbocker, C ;

Toyofuku, W ;

Lowe, M ;

Herliczek, TW ;

Bacus, SS .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (20) :1566-1575

[3] The prognosis of small primary breast cancers [J].

Kollias, J ;

Murphy, CA ;

Elston, CW ;

Ellis, IO ;

Robertson, JFR ;

Blamey, RW .

EUROPEAN JOURNAL OF CANCER, 1999, 35 (06) :908-912

[4]

Reed W, 2000, CANCER, V88, P804, DOI 10.1002/(SICI)1097-0142(20000215)88:4<804::AID-CNCR11>3.0.CO

[5]

2-Y

[6]

ROSNER D, 1991, CANCER, V68, P1482, DOI 10.1002/1097-0142(19911001)68:7<1482::AID-CNCR2820680704>3.0.CO

[7]

2-J

[8] Revision of the American Joint Committee on Cancer staging system for breast cancer [J].

Singletary, SE ;

Allred, C ;

Ashley, P ;

Bassett, LW ;

Berry, D ;

Bland, KI ;

Borgen, PI ;

Clark, CG ;

Edge, SB ;

Hayes, DF ;

Hughes, LL ;

Hutter, RVP ;

Morrow, M ;

Page, DL ;

Recht, A ;

Theriault, RL ;

Thor, A ;

Weaver, DL ;

Wieand, HS ;

Greene, FL .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) :3628-3636

← 1 →